BR112017017142A2 - métodos e composições para redução de produtos de amplificação não específicos - Google Patents

métodos e composições para redução de produtos de amplificação não específicos

Info

Publication number
BR112017017142A2
BR112017017142A2 BR112017017142A BR112017017142A BR112017017142A2 BR 112017017142 A2 BR112017017142 A2 BR 112017017142A2 BR 112017017142 A BR112017017142 A BR 112017017142A BR 112017017142 A BR112017017142 A BR 112017017142A BR 112017017142 A2 BR112017017142 A2 BR 112017017142A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
amplification products
specific amplification
reducing non
Prior art date
Application number
BR112017017142A
Other languages
English (en)
Other versions
BR112017017142B1 (pt
Inventor
Zhitong Liu
Original Assignee
Paragon Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paragon Genomics Inc filed Critical Paragon Genomics Inc
Publication of BR112017017142A2 publication Critical patent/BR112017017142A2/pt
Publication of BR112017017142B1 publication Critical patent/BR112017017142B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/301—Endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/191—Modifications characterised by incorporating an adaptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/101—Temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis

Abstract

métodos, composições, sistemas e kits para amplificar ou melhorar a amplificação de produtos de amplificação específicos para o alvo pela redução dos produtos de amplificação não específicos (por exemplo, dímeros de iniciadores) ao amplificar várias regiões de nucleotídeos diferentes. os métodos, composições, sistemas e kits aqui descritos podem incluir ou incluem o uso de uma ou mais resolvases que reconhecem e se ligam a e/ou cortam uma estrutura de dna aberrante.
BR112017017142-2A 2015-02-11 2016-02-11 Método para redução dos produtos de amplificação não específicos a partir de uma reação de extensão de iniciador dependente de molde BR112017017142B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562114788P 2015-02-11 2015-02-11
US62/114,788 2015-02-11
US201562150600P 2015-04-21 2015-04-21
US62/150,600 2015-04-21
PCT/US2016/017454 WO2016130746A1 (en) 2015-02-11 2016-02-11 Method and compositions for reducing non-specific amplification products

Publications (2)

Publication Number Publication Date
BR112017017142A2 true BR112017017142A2 (pt) 2018-04-03
BR112017017142B1 BR112017017142B1 (pt) 2024-03-12

Family

ID=56566583

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017142-2A BR112017017142B1 (pt) 2015-02-11 2016-02-11 Método para redução dos produtos de amplificação não específicos a partir de uma reação de extensão de iniciador dependente de molde

Country Status (10)

Country Link
US (1) US9464318B2 (pt)
EP (1) EP3256584B1 (pt)
JP (1) JP6755890B2 (pt)
KR (1) KR20170110721A (pt)
CN (1) CN107532166A (pt)
AU (1) AU2016219288B2 (pt)
BR (1) BR112017017142B1 (pt)
CA (1) CA2976251C (pt)
ES (1) ES2795404T3 (pt)
WO (1) WO2016130746A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10421993B2 (en) 2015-02-11 2019-09-24 Paragon Genomics, Inc. Methods and compositions for reducing non-specific amplification products
CN107058573B (zh) * 2016-06-13 2020-07-10 艾吉泰康生物科技(北京)有限公司 一种利用Cas9/gRNA系统构建扩增子文库的方法
WO2018132459A1 (en) 2017-01-10 2018-07-19 Paragon Genomics, Inc. Methods and compositions for reducing redundant molecular barcodes created in primer extension reactions
EP4253565A2 (en) * 2017-01-24 2023-10-04 Vastogen, Inc. Methods for constructing copies of nucleic acid molecules
WO2019166565A1 (en) * 2018-03-02 2019-09-06 F. Hoffmann-La Roche Ag Generation of double-stranded dna templates for single molecule sequencing
US11976275B2 (en) 2018-06-15 2024-05-07 Kapa Biosystems, Inc. Generation of double-stranded DNA templates for single molecule sequencing
JPWO2020145351A1 (ja) * 2019-01-09 2021-11-25 国立研究開発法人理化学研究所 薬物動態関連遺伝子の網羅的配列解析法とそれに使用されるプライマーセット
US11396674B2 (en) * 2019-02-22 2022-07-26 Gianluca ROMA Multiplex nucleic acid amplification and library preparation
US10941453B1 (en) 2020-05-20 2021-03-09 Paragon Genomics, Inc. High throughput detection of pathogen RNA in clinical specimens
CN114369649A (zh) * 2022-02-08 2022-04-19 山东见微生物科技有限公司 一种特异的选择扩增及多重pcr方法和应用
US11680293B1 (en) 2022-04-21 2023-06-20 Paragon Genomics, Inc. Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US20040002156A1 (en) * 2002-06-26 2004-01-01 Stratagene Selective cloning of homoduplex nucleic acids
DE602004024034D1 (de) * 2003-01-29 2009-12-24 454 Corp Nukleinsäureamplifikation auf basis von kügelchenemulsion
EP1574570A1 (en) 2004-03-12 2005-09-14 Universität Regensburg Process for reducing the number of mismatches in double stranded polynucleotides
ATE489396T1 (de) * 2004-08-24 2010-12-15 Cornell Res Foundation Inc Detektion von nucleinsäureunterschieden mit hilfe von endonucleasespaltungs-/ligaseabgabereaktionen und kapillarelektrophoresen oder mikroarrays
WO2006127423A2 (en) 2005-05-18 2006-11-30 Codon Devices, Inc. Methods of producing polynucleotide libraries using scarless ligation
US8716190B2 (en) * 2007-09-14 2014-05-06 Affymetrix, Inc. Amplification and analysis of selected targets on solid supports
US9540637B2 (en) * 2008-01-09 2017-01-10 Life Technologies Corporation Nucleic acid adaptors and uses thereof
US8586310B2 (en) 2008-09-05 2013-11-19 Washington University Method for multiplexed nucleic acid patch polymerase chain reaction
EP3495497B1 (en) 2011-04-28 2021-03-24 Life Technologies Corporation Methods and compositions for multiplex pcr
US9523121B2 (en) 2013-01-13 2016-12-20 Uni Taq Bio Methods and compositions for PCR using blocked and universal primers
WO2015063154A1 (en) 2013-10-31 2015-05-07 Multiplicom N.V. Blocking primers in multiplex pcr based assays

Also Published As

Publication number Publication date
WO2016130746A1 (en) 2016-08-18
CN107532166A (zh) 2018-01-02
US9464318B2 (en) 2016-10-11
CA2976251C (en) 2023-08-22
ES2795404T3 (es) 2020-11-23
AU2016219288B2 (en) 2021-10-28
EP3256584B1 (en) 2020-03-25
BR112017017142B1 (pt) 2024-03-12
JP2018506307A (ja) 2018-03-08
KR20170110721A (ko) 2017-10-11
JP6755890B2 (ja) 2020-09-16
US20160230222A1 (en) 2016-08-11
AU2016219288A1 (en) 2017-08-17
EP3256584A1 (en) 2017-12-20
EP3256584A4 (en) 2018-08-15
CA2976251A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
BR112017017142A2 (pt) métodos e composições para redução de produtos de amplificação não específicos
BR112017017086A2 (pt) monitoramento de produtos de escavação para equipamento de terraplenagem
BR112019003327A2 (pt) nucleases manipuladas de alvo específico
BR112018069225A2 (pt) sistema de endereçamento de alvo
BR112018002451A2 (pt) estruturas de ligação com antígeno para moléculas alvo
CO2018010316A2 (es) Inmunomoduladores
BR112018011089A2 (pt) composições e métodos para a imuno-oncologia
EA201891532A1 (ru) Композиции и способы лечения гемоглобинопатий
CL2018000744A1 (es) Anticuerpos anti-tigit (inmunoreceptor de linfocitos t con dominios ig e itim) y metodos de uso.
BR112019009019A2 (pt) esteroides e conjugados de proteínas dos mesmos
BR112018012138A2 (pt) moléculas de anticorpo para pd-1 e usos das mesmas
BR112017019591A2 (pt) imunomodulares
BR112017012704A2 (pt) imunomoduladores
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
BR112018006237A2 (pt) proteínas de ligação a pd-1 e métodos de uso das mesmas
BR112017020054A2 (pt) anticorpos para icos
BR112017016080A2 (pt) polinucleotídeo, sistema crispr, dois polinucleotídeos e métodos de modificação de uma molécula, de redução de modificação fora do alvo e de aumento da modificação específica de alvo
CL2020000937A1 (es) Anticuerpo multiespecífico.
BR112017014341A2 (pt) método e sistema para tratamento, estabilização, ou redução da gravidade ou progressão de uma doença de fígado gorduroso não alcoólica, e, composição.
BR112016019267A2 (pt) métodos e composições para perfil de dna
BR112017012351A2 (pt) compostos inibidores de bcl xl que têm permeabilidade celular baixa e conjugados de fármaco-anticorpo que incluem os mesmos
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
CL2017002596A1 (es) Neutralización del virus chikungunya mediada por anticuerpos
BR112016025627A2 (pt) biomarcadores e combinações dos mesmos para diagnóstico de tuberculose
BR112018070578A2 (pt) composições, sistemas, kits, e métodos para tratar uma infecção

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/02/2016, OBSERVADAS AS CONDICOES LEGAIS